Characteristics | Survivor (n = 846) | Non-survivors (n = 396) | p-value |
---|---|---|---|
Age at ICU admission, years | 67.5 ± 11.4 | 69.7 ± 11.7 | < 0.001 |
Age group | Â | Â | 0.011 |
 < 65 years | 339 (40.1%) | 129 (32.6%) |  |
 ≥ 65 years | 507 (59.9%) | 267 (67.4%) |  |
Gender | Â | Â | 0.631 |
 Male | 478 (56.5%) | 218 (55.1%) |  |
 Female | 368 (43.5%) | 178 (44.9%) |  |
Smoking | Â | Â | 0.346 |
 No | 602 (71.2%) | 292 (73.7%) |  |
 Yes | 244 (28.8%) | 104 (26.3%) |  |
HTN | Â | Â | 0.468 |
 No | 431 (50.9%) | 193 (48.7%) |  |
 Yes | 415 (49.1%) | 203 (51.3%) |  |
Hyperlipidemia | Â | Â | 0.098 |
 No | 585 (69.1%) | 292 (73.7%) |  |
 Yes | 261 (30.9%) | 104 (26.3%) |  |
DM | Â | Â | 0.067 |
 No | 705 (83.3%) | 313 (79.0%) |  |
 Yes | 141 (16.7%) | 83 (21.0%) |  |
COPD | Â | Â | 0.435 |
 No | 492 (58.2%) | 221 (55.8%) |  |
 Yes | 354 (41.8%) | 175 (44.2%) |  |
HF | Â | Â | 0.014 |
 No | 720 (85.1%) | 315 (79.5%) |  |
 Yes | 126 (14.9%) | 81 (20.5%) |  |
CKD | Â | Â | 0.109 |
 No | 774 (91.5%) | 351 (88.6%) |  |
 Yes | 72 (8.5%) | 45 (11.4%) |  |
Metastasis | Â | Â | < 0.001 |
 No | 436 (51.5%) | 151 (38.1%) |  |
 Yes | 410 (48.5%) | 245 (61.9%) |  |
Admission type | Â | Â | < 0.001 |
 Elective | 242 (28.6%) | 15 (3.8%) |  |
 Emergency | 587 (69.4%) | 373 (94.2%) |  |
 Urgent | 17 (2.0%) | 8 (2.0%) |  |
ICU type | Â | Â | < 0.001 |
 MICU | 332 (41.3%) | 258 (65.2%) |  |
 SICU/TSICU | 291 (36.2%) | 76 (19.2%) |  |
 CCU/CSRU | 180 (22.4%) | 62 (15.7%) |  |
SAPS II | 35.0 (29.0–41.5) | 43.0 (36.0–53.0) | < 0.001 |
SOFA | 2.0 (1.0–4.0) | 4.0 (2.0–6.0) | < 0.001 |
ICU LOS | 2.0 (1.2–4.0) | 2.8 (1.6–5.7) | < 0.001 |
MV | Â | Â | < 0.001 |
 No | 554 (69.0%) | 202 (51.0%) |  |
 Yes | 249 (31.0%) | 194 (49.0%) |  |
Vasopressor | Â | Â | 0.007 |
 No | 634 (79.0%) | 285 (72.0%) |  |
 Yes | 169 (21.0%) | 111 (28.0%) |  |
DNR | Â | Â | < 0.001 |
 No | 816 (96.5%) | 342 (86.4%) |  |
 Yes | 30 (3.5%) | 54 (13.6%) |  |